ITGAL and non-small cell lung carcinoma: It has been shown that the expression level of ITGAL is associated with the efficacy of ICI in patients with NSCLC (29), suggesting that ITGAL might be useful as a molecular marker of NSCLC and as a predictor of ICI efficacy.